Evidence map›Paper›PMID 32380660›Full record

Trial reportNutrients2020

The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.

Susanne Macher, Cornelia Herster, Magdalena Holter, Martina Moritz, Eva Maria Matzhold, Tatjana Stojakovic, Thomas R Pieber, Peter Schlenke, Camilla Drexler, Karin Amrein

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01787526 (High Dose Intravenous Iron in Blood Donors With Iron Deficiency), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01787526 phase3completednot on this map

High Dose Intravenous Iron in Blood Donors With Iron Deficiency: a Randomized, Controlled Trial

TypeinterventionalSponsorMedical University of GrazRan2014 to 2016Enrolled176ConditionsIron DeficiencyArmsferric carboxymaltose, oral iron
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Pilot Study to Gain First Indications for the Impact of a 3-Month's Oral Intake of a Sucrosomial Iron Supplement on Hemoglobin in Iron-Deficient Blood Donors.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Headache as a Neurologic Manifestation of Systemic Disease.Current treatment options in neurology · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Ethical Issues and Management of Fetal Hemolytic Anemia Caused by Anti-Rh17 in a Multipara with Rare -D- Phenotype.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2021
    Article
  17. Observational
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Susanne MacherDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, 8036 Graz, Austria.
Cornelia HersterDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, 8036 Graz, Austria.
Magdalena HolterInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0002-8355-3617
Martina MoritzDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, 8036 Graz, Austria.
Eva Maria MatzholdDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, 8036 Graz, Austria.
Tatjana StojakovicClinical Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Graz, 8036 Graz, Austria.
Thomas R PieberDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.
Peter SchlenkeDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, 8036 Graz, Austria.
Camilla DrexlerDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, 8036 Graz, Austria.
Karin AmreinDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.
Medical University of Graz · AT

Funding

CSRD VA 1
6 · The paper itself

Abstract

METHODS/

designProspective, randomized, controlled, single-centre trial. (ClinicalTrials.gov: NCT01787526).

settingTertiary care center in Graz, Austria.

participants176 (138 female and 38 male) whole-blood and platelet apheresis donors aged ≥ 18 and ≤ 65 years with iron deficiency (ferritin ≤ 30ng/mL at the time of blood donation).

interventionsIntravenous iron (1 g ferric carboxymaltose, n = 86) or oral iron supplementation (10 g iron fumarate, 100 capsules, n = 90). MEASUREMENTS: Clinical symptoms were evaluated by a survey before iron therapy (visit 0, V0) and after 8-12 weeks (visit 1, V1), including questions about symptoms of restless legs syndrome (RLS), chronic fatigue syndrome (CFS), sleeping disorders, quality of life and symptoms like headaches, dyspnoea, dizziness, palpitations, pica and trophic changes in fingernails or hair.

resultsWe found a significant improvement in the severity of symptoms for RLS, fatigue and sleep quality (

conclusionIron supplementation in iron-deficient blood donors may be an effective strategy to improve symptoms related to iron deficiency and the wellbeing of blood donors.

Indexed as

Blood DonorsDietary SupplementsQuality of LifeAdministration, OralAdolescentAdultAgedAnemia, Iron-DeficiencyFatigue Syndrome, ChronicFemaleFerric CompoundsHumansInfusions, IntravenousIron, DietaryMaleMaltoseferric carboxymaltoseFerric CompoundsIron, DietaryMaltoseblood donorfatigueiron deficiencyiron supplementationRLS

Identifiers

PMID32380660
PMCPMC7284357
OpenAlexW3015022340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.